Pelthos Therapeutics Inc (PTHS)
AMEXHealth CareBiotechnologySnapshot 2026-09-04
$24.35-0.04%
Close 2026-09-04 · 1-day change
AMEXHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · PTHS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenues | — | 16.8 | — | — | — | — |
| Cost of Revenues | 9.3 | 4.0 | — | — | — | — |
| Operating Expenses & Income | ||||||
| Selling, General & Admin | 86.9 | 42.5 | — | — | — | — |
| R&D Expenses | 1.3 | 1.2 | 1.2 | 2.6 | 0.4 | — |
| Operating Income | (57.8) | (32.4) | (7.6) | (6.9) | (2.3) | — |
| Earnings from Continuing Operations | ||||||
| Interest Expense | — | 3.0 | — | — | — | — |
| Other Non-Operating Income / Expenses | (21.2) | (18.3) | (0.4) | (0.5) | (0.1) | — |
| EBT, Incl. Unusual Items | (78.9) | (50.7) | — | (7.4) | (2.5) | — |
| Income Tax Expense | — | (7.4) | — | — | — | — |
| Net Income | ||||||
| Net Income | (71.6) | (43.3) | (8.0) | (7.4) | (2.5) | — |
| Per Share | ||||||
| Basic EPS | (20.22) | (23.04) | (1.43) | (5.78) | 5.65 | — |
| Diluted EPS | (20.22) | (23.04) | (1.43) | (5.78) | — | — |
| Basic Weighted Avg Shares | 3.5 | 1.9 | 5.6 | 1.3 | 0.4 | — |
| Diluted Weighted Avg Shares | 3.5 | 1.9 | 5.6 | 1.3 | — | — |
| Supplemental | ||||||
| EBIT | (57.8) | (32.4) | (7.6) | (6.9) | (2.3) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.